Bridge City Capital LLC Sells 86,981 Shares of Pediatrix Medical Group, Inc. $MD

Bridge City Capital LLC reduced its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 36.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 149,948 shares of the company’s stock after selling 86,981 shares during the period. Bridge City Capital LLC owned about 0.17% of Pediatrix Medical Group worth $3,207,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of MD. Global Retirement Partners LLC grew its position in Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after acquiring an additional 1,365 shares during the last quarter. Transamerica Financial Advisors LLC bought a new position in Pediatrix Medical Group during the fourth quarter valued at approximately $30,000. Eurizon Capital SGR S.p.A. bought a new position in Pediatrix Medical Group during the fourth quarter valued at approximately $33,000. Blue Trust Inc. bought a new position in Pediatrix Medical Group during the fourth quarter valued at approximately $37,000. Finally, TD Private Client Wealth LLC bought a new position in Pediatrix Medical Group during the fourth quarter valued at approximately $39,000. 97.71% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Shirley A. Weis sold 36,028 shares of the firm’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.80% of the stock is owned by insiders.

Analyst Ratings Changes

MD has been the topic of a number of recent research reports. Jefferies Financial Group reiterated a “buy” rating and set a $27.00 price target on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Deutsche Bank Aktiengesellschaft set a $19.00 target price on shares of Pediatrix Medical Group in a report on Friday, February 20th. Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Friday, March 27th. UBS Group raised their target price on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Finally, Truist Financial raised their target price on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a report on Monday, April 13th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and an average price target of $22.50.

Pediatrix Medical Group Stock Up 0.5%

Shares of Pediatrix Medical Group stock opened at $24.29 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.33 and a current ratio of 1.33. Pediatrix Medical Group, Inc. has a 52-week low of $11.84 and a 52-week high of $24.99. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of 11.79 and a beta of 0.69. The company’s 50 day moving average price is $22.42 and its 200-day moving average price is $21.73.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The firm had revenue of $476.20 million for the quarter, compared to analysts’ expectations of $465.83 million. During the same quarter last year, the business earned $0.33 earnings per share. The business’s revenue was up 3.9% on a year-over-year basis. Equities research analysts forecast that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.